​

Funding Round

Series A - GlycoEra

Series A - GlycoEra

Investment Firm

Overview

GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.

Announced Date

Jan 05, 2024

Funding Type

Series A

Highlights

Location

Switzerland, Europe

Social

Investor Lead

Bristol-Myers Squibb

Bristol-Myers Squibb

Bristol-Myers Squibb is a early_stage_venture and venture firm.

Participant Investors

4

Investor Name
Participant Investor5AM Ventures
Participant InvestorSofinnova Partners
Participant InvestorBristol-Myers Squibb
Participant InvestorRoche Venture Fund

Round Details and Background

GlycoEra raised an undisclosed amount on 2024-01-05 in Series A

GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 05, 2021
Series A - GlycoEra
4-49.3M
Jan 05, 2024
Series A - GlycoEra
4-undefined

Recent Activity

There is no recent news or activity for this profile.